ArticleThe Journal of physiology2000
The subunit dominates the relaxation kinetics of heteromeric neuronal nicotinic receptors.
Article in The Journal of physiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 11 citations in OpenAlex.
- Cellular, Synaptic and Network Effects of Acetylcholine in the Neocortex.Frontiers in neural circuits · 2019Review
- Layer- and cell type-selective co-transmission by a basal forebrain cholinergic projection to the olfactory bulb.Nature communications · 2017Article
- Olfactory Bulb Deep Short-Axon Cells Mediate Widespread Inhibition of Tufted Cell Apical Dendrites.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017Article
- Single-channel properties of α3β4, α3β4α5 and α3β4β2 nicotinic acetylcholine receptors in mice lacking specific nicotinic acetylcholine receptor subunits.The Journal of physiology · 2013Article
- Fast synaptic transmission in the goldfish CNS mediated by multiple nicotinic receptors.The Journal of physiology · 2011Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ACh-induced voltage-jump relaxation currents of the nicotinic receptors formed by pair-wise expression of the rat alpha2, alpha3, or alpha4 subunits with the beta2 or beta4 subunit in Xenopus oocytes were fitted best by the sum of two exponentials and a constant between -60 and -150 mV. As the ACh concentration approached zero, the relaxation time constants approached limiting values that should equal the single-channel burst duration at low ACh concentrations and the synaptic current decay time constants. beta4 co-expression prolonged the zero ACh concentration limits for the relaxation time constants. The fast beta4 zero ACh concentration limits ranged from 40 to 121 ms between -60 and -150 mV, and the slow beta4 zero ACh concentration limits ranged from 274 to 1039 ms. In contrast, the fast beta2 limits were 4-6 ms over the same voltage range and the slow beta2 limits were 30-53 ms. Expression with the beta4 subunit increased the voltage sensitivity of the alpha2, alpha3 and slow alpha4 relaxation time constants but not that of the fast alpha4 relaxation time constant. Reducing the temperature from 22 C to 8-9 C increased the alpha4beta2 and alpha3beta4 relaxation time constants 2.3- to 6.6-fold and reduced the fractional amplitude of the fast relaxation component. It also increased the voltage dependence of the fast alpha3beta4 relaxation time constant and decreased that of the slow time constant. The Q10 for alpha4beta2 and alpha3beta4 relaxation time constants ranged from 1.9 to 3.9 between 10 and 20 C. The beta subunit appears to have a dominant influence on the voltage-jump relaxation kinetics of heteromeric neuronal nicotinic receptors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.